The stock of Sabra Health Care REIT Inc. (NASDAQ:SBRA) increased by $0.28 on Wednesday to $12.56, up 2.32 percent. The last five days have seen an average of 1,199,720 shares of common stock traded. 11 times new highs were reached in the current year, with a gain of $0.12. The average number of shares traded over the last 20 days was 1,961,145, while the average volume over the last 50 days totaled 1,996,306.
SBRA stock dropped -2.90% since last month. On 08/18/23, the company’s shares reached a one-month low of $11.73. The stock touched a high of $15.34 on 02/02/23, after rallying from a low of $10.08 in 52 weeks. The price of SBRA stock has risen by 1.09% or $0.12 this year, reaching a new high 11 times. Still, the stock price is down -18.08% from the 52-week high.
Valuation Metrics
Beta for the stock is 1.30. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 4.66, the price-to-book (PB) ratio of 0.99, and the price-to-cash flow ratio of 14.38.
Company paid $0.30 per share in dividends, remained unchanged from $0.30 last year. A $0.15 dividend decrease was reported on Wednesday May 6 2020.
Financial Health
The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.82, and the total debt to equity ratio is 0.82. As far as profitability goes, gross margin for the trailing twelve months is 74.00% percent. Sabra Health Care REIT Inc.’s operating margin stood at 1.30% for the same period. Based on annual data, it had gross profit of $140.66 million and revenue of $624.81 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. SBRA’s return on assets (ROA) during the last 12 months has been -2.20%. There was a 0.60% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -4.00%.
Earnings Surprise
According to Sabra Health Care REIT Inc.’s quarterly financial report for the quarter that ended June 29. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $161.17 million, while revenues rose by 3.23% to $161.32 million. It was predicted that Sabra Health Care REIT Inc.’s quarterly earnings would be $0.09, but it ended up being $0.1. EBITDA was $102.47 million for the quarter. At the end of Sabra Health Care REIT Inc.’s most recent quarter ended June 29, its total debt was $2.42 billion. Equity owned by shareholders amounts to $231.22 million.
Technical Picture
Here’s a quick look at Sabra Health Care REIT Inc.’s (SBRA) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 60.47%, suggesting the stock is Neutral, with a 15.33% historical volatility rate.
The stochastic %K and %D were 57.21% and 41.25% respectively, while the average true range (ATR) was 0.25. Based on the 14-day stochastic reading of 79.23%, the RSI (14) reading is 55.60%. On the 9-day MACD Oscillator, the stock is at 0.18, and the 14-day reading is at 0.12.
Analyst Ratings
In its most recent analyst report, BofA Securities raised its rating on Sabra Health Care REIT Inc. (NASDAQ: SBRA) to a Neutral. Prior to this, analysts firm rated the stock as an Underperform. Analysts have assigned Sabra Health Care REIT Inc. (SBRA) an Hold rating. SBRA is a stock that is recommended for selling by 1 brokerage firm, while 10 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.
What is SBRA’s price target for the next 12 months?
The current consensus forecast for the stock is between $11.00 and $15.00, with a median target price of $13.00. In analyzing these forecasts, the average price target given by analysts for Sabra Health Care REIT Inc. (SBRA) is $13.21.
